In order to better promote the development of this treatment in China, experts in pain and functional neurosurgery from the Pain Management Committee of the Chinese Medical Association Anesthesiology Branch, the Neuromodulation Therapy Committee of the Chinese Medical Association, and the Pain Branch of the Chinese Medical Association recently met in the beautiful seaside city of Sanya to discuss the mechanism of action, indications, clinical efficacy, treatment procedures, and adverse events by reviewing foreign clinical treatment guidelines for chronic pain and related literature and combining them with the current experience of relevant domestic clinical The mechanism of action, indications, clinical efficacy, treatment procedures and adverse events of this treatment were discussed in detail and in depth by reviewing overseas clinical treatment guidelines for chronic pain and related literature, combined with the current experience of relevant clinical centers in China. The patient selection section is summarized as follows: Spinal cord and peripheral electrical stimulation therapy is currently used to treat chronic intractable neuropathic pain. After reviewing the relevant foreign literature, drawing on the relevant treatment guidelines and the experience carried out in China, the participating experts discussed the following indications for SCS and PNS: indications for SCS: pain syndrome after low back surgery, complex focal pain syndrome, pain caused by peripheral ischemic disease, intractable angina, intractable chronic lower back pain, peripheral neuropathy (diabetic neuropathy, etc.), post-herpetic Neuralgia, pain after nerve injury (residual limb pain, phantom limb pain, brachial plexus injury, etc.; PNS indications: In most cases, peripheral nerve stimulation should only be used in patients with neurogenic pain limited to a single nerve distribution area, and the reported scope of application includes the following chronic pain disorders: postherpetic neuralgia; post-traumatic or post-surgical neuropathic pain,
It has been reported in the following chronic pain disorders: postherpetic neuralgia; post-traumatic or post-surgical neuropathic pain, including infrapopliteal, suprapopliteal and greater occipital nerve; classic migraine; greater occipital neuralgia; referred headache; complex focal pain syndrome; inguinal pain after hernia; coccygeal pain; myalgia; etc. Due to the limited experience of domestic use, it is for clinical reference. At the same time, the participating experts believe that patients receiving neuroelectrical stimulation treatment need to meet the following basic conditions: patients with chronic moderate to severe pain with a VAS score ≥ 5 and who have undergone conventional treatment with poor efficacy or who cannot tolerate the side effects of treatment; patients with clear pathological changes or clinical diagnosis of painful diseases suitable for receiving spinal or peripheral electrical stimulation treatment; patients without severe psychological and/or psychiatric disorders and/or non therapeutic drug dependence; patients undergoing treatment must have been evaluated with electrical stimulation test therapy and the test results indicate effective pain relief (≥50% reduction in VAS score); complete patient informed consent must be obtained prior to testing and/or implantation of the system; the patient and/or patient’s family has reasonable expectations for the treatment and is able to cooperate with the clinician in the electrical stimulation treatment. Electrical stimulation of the spinal cord and peripheral nerves is an important treatment for intractable chronic pain as a result of ineffective or unsatisfactory conventional treatment, with the advantages of being reversible and not damaging neurological function. The experts at the meeting unanimously hope that this treatment method will be correctly understood, and its application will be promoted scientifically, actively and steadily firstly in the units that are in a position to do so, and clinical centers for this treatment will be actively established in China to be able to train more doctors who can carry out this treatment and promote the popularization of this treatment. It is believed that with the support of relevant associations and the efforts of clinicians, especially with multidisciplinary cooperation, clinical departments and basic research, this treatment will definitely benefit the majority of pain patients and will promote the development of pain medicine.